https://www.selleckchem.com/pr....oducts/etomoxir-na-s
The burden and treatment landscape of rheumatoid arthritis (RA) is poorly understood. This research aimed to identify evidence on quality of life, caregiver burden, economic burden, treatment patterns and clinical outcomes for patients with moderate RA in the United Kingdom. A systematic literature review was performed across multiple databases and screened against pre-defined inclusion criteria. 2,610 records were screened; seven studies presenting evidence for moderate RA were included. These patients were found to incur subs
Like
Comment
Share
